The majority of patients with GDM can achieve optimal glycemic control through evidence-based dietary and exercise interventions; however, for those who fail to effectively control blood glucose, healthcare providers encounter a significant challenge in the early identification of high-risk cohorts and the strategic initiation of insulin therapy. The gene discussed is INS; the disease is gestational diabetes.